Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, China.
Curr Neuropharmacol. 2018;16(9):1306-1313. doi: 10.2174/1570159X16666180412094655.
Tumor necrosis factor receptor-associated factor (TRAF) is an important binding protein of tumor necrosis factor (TNF) superfamily and the toll/IL-1 receptor (TIR) superfamily, which play an important role in innate immunity and acquired immunity. TRAFs family have 7 members (TRAF1-7), and TRAF6 has its special facture and biological function. TRAF6 has two special domains: C-terminal domain and N-terminal domain, which could integrate with multiple kinases and regulate signaling pathway function as an E3 ubiquitin ligase. Studies have increasingly found that TRAF6 is closely related to central nervous system diseases, such as stroke, Traumatic brain injury, neurodegenerative diseases and neuropathic pain. Further research on the pathophysiological mechanism may be expected to become the new targets for the treatment of central nervous system diseases.
肿瘤坏死因子受体相关因子(TRAF)是肿瘤坏死因子(TNF)超家族和 Toll/IL-1 受体(TIR)超家族的重要结合蛋白,在固有免疫和获得性免疫中发挥重要作用。TRAF 家族有 7 个成员(TRAF1-7),TRAF6 具有其特殊的结构和生物学功能。TRAF6 有两个特殊的结构域:C 端结构域和 N 端结构域,可与多种激酶结合,并作为 E3 泛素连接酶调节信号通路的功能。研究越来越发现,TRAF6 与中枢神经系统疾病密切相关,如中风、创伤性脑损伤、神经退行性疾病和神经病理性疼痛。进一步研究其病理生理学机制,可能成为治疗中枢神经系统疾病的新靶点。